Quarterly report pursuant to Section 13 or 15(d)

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Revenue Recognition (Details)

v3.21.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Revenue Recognition (Details) - Customer
9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Four Customers [Member] | Revenues [Member] | Customer Concentration Risk [Member]    
Revenue Recognition [Abstract]    
Number of customers 4  
Percentage of consolidated revenues 74.00%  
Three Customers [Member] | Revenues [Member] | Customer Concentration Risk [Member]    
Revenue Recognition [Abstract]    
Number of customers   3
Percentage of consolidated revenues   82.00%
Biotest License Agreement [Member]    
Revenue Recognition [Abstract]    
Amortization period 22 years